A NYC Millionaire’s Blueprint Review: Is Whitney Tilson’s N.E.W. System Worth It?
“Last year I stood on stage at Rockefeller Center for the first New York City mayoral debate.” That is how Whitney Tilson’s “Ripping Point” presentation opens, and the scene is real: he did stand on that stage, in the June 2025 Democratic primary debate alongside Zohran Mamdani and Andrew Cuomo, and the presentation uses that personal witness to set up its thesis, that America has hit a “ripping point” and the market is splitting in two. The product is the same machine as his sibling Civil War campaign, the Stansberry Score and the N.E.W. System, and the free picks are the same generous pair: Garmin to buy, Rivian to sell. Here is our complete review. We describe the political framing factually and neutrally; the investing case does not depend on it.
Images to be added when available.
The Presenter
Whitney Tilson’s credibility block is among the most verifiable in this industry. He co-founded Teach for America before Wall Street, managed more than $200 million at Kase Capital Management, earned the CNBC nickname “the Prophet,” called the dot-com crash in 2000, flagged Bear Stearns and Lehman before the crisis, appeared on 60 Minutes at the December 2008 bottom, warned four months ahead of the 2022 selloff, and ran for mayor of New York City. The short-seller record is public: the Lumber Liquidators investigation he presented on 60 Minutes in 2015, and the FBI tip about Jeffrey Epstein. The Ukraine aid work, six trips, nearly $22 million raised, a month along the front lines, is documented in his public writing.
The personal-detail proof is the presentation’s signature move: “Bill introduced me to my wife soon after we graduated from Harvard in 1990. Back then, she called him Billy.” The early-internet track record is presented with split-adjusted honesty: “I was early on some of the biggest stocks to emerge at that time, including Netflix, when it was at 78 cents a share,” framed as “I was early on” rather than “I bought at,” which is the correct way to state it. Nothing in the credibility block fails verification; the softenings are in the framing, not the facts.
The candor on prediction quality appears here too: “Now, I haven’t always been accurate in all of my predictions, but over the years, I think I’ve done a pretty good job of making good predictions.” Readers of our Rushmore Gold review will recognize the same architecture; the voice is durable, and the vehicle has changed from a resource advisory to a systematic AI portfolio.
The Big Idea
The thesis is the “ripping point”: AI is splitting the economy and the market into winners and losers faster than individuals can process. “We’ve hit the ripping point. And most Americans have no idea what to do about it.” The macro frame is the K-shaped economy, “the two Americas we’re living in,” and the market evidence is real 2026 history: Gartner’s 31% one-day plunge in February and roughly half its value lost in months, Duolingo’s 75% decline from its May 2025 peak, Oracle’s reversal, the consulting and software damage across Accenture, S&P Global, and FactSet, against the mirror-image winners, Micron, Celestica, Lam Research.
The mechanism is the machine, not a stock: the Stansberry Score, “crunching them down into a single number from 0 to 100,” and the N.E.W. System’s quarterly portfolio built from it: “Once we found our highest scoring stocks, the best of the best, we then trained our A.I. to simulate the future outcomes of thousands of different types of portfolios. Using every combination of companies imaginable.” Human oversight is stated: “you won’t be blindly following a computer. I still vet each recommendation for you along with a special committee of experts.”
The why-not-DIY answer is concrete, down to the team: “It takes vast amounts of data, which costs hundreds of thousands of dollars a year to access. And it takes a hell of a lot of coding, developing and testing, involving a team that has a combined 76 years of experience… and even a PhD in astrophysics.” The democratization argument runs through the Renaissance Technologies story, “$1,000 investment in 1988 would have grown to $46 billion by 2024… The problem is it’s impossible to get your money in the door.”
The factual spine holds up where it can be checked: Amazon’s ~14,000 corporate role cut, the millionth Amazon robot, the 17-month white-collar contraction, METR’s roughly seven-month doubling research, and the “more than 80% of the stock market is now being run by algorithms” estimate all match published reporting. The METR phrasing (“AI’s capability has doubled”) is an interpretation of what METR actually measures, autonomous task length, which is worth keeping straight.
The Key Claims
The headline claims, quoted:
- The campaign subtitle: “A NYC Millionaire’s Blueprint for Profiting from the Extreme, Irreversible Changes Sweeping Our Country.”
- “You’d have turned every hundred thousand dollars of your money into three hundred and $39,000 with less risk than the stock market” (i.e., $100,000 into $339,000).
- “It’s creating an average of 1,000 new millionaires every single day,” with CNBC’s “largest wealth creation spree in recent history” and MIT’s “unprecedented” framing, all quoted from real coverage.
- The stakes: “Some stocks are compounding wealth at an exponential rate… while others are hemorrhaging value, headed toward irrelevance. For people with money in the market, this split will be more dangerous than anything we’ve seen in decades.”
The score demonstration pairs real stocks with real outcomes: Cadence 86, Nvidia 74 “all the way back in 2016,” Agnico Eagle 89 “already up as much as 118% over the past year,” versus “Resolve AI, which only scored a 37 in our back tests and would have wiped out 77% of your money since the summer of 2024,” “multi-sensor AI” at 46 (crashed 76%), and Jet.ai at 15 (wiped out entirely).
The compliance edges, named honestly: the $339,000 figure is a backtest spoken as a concrete outcome, with “according to our historical study” as the only provenance; “less risk than the stock market” never defines the risk measure for a concentrated model portfolio; the Rivian sell is unhedged (“If you own this one, I’d get out immediately”) where the buying claims all carry “could”; the cherry-picked backtest winners (Nutex Health “a 1,100% gain in less than a year,” AppLovin “before it shot up 2,500%”) present the system’s greatest hits without the losers any factor screen produces; and the social-unrest imagery, real reported events, is used as rhetorical fuel for a financial pitch. One unverifiable attribution: “Stanford researchers have proven that AI now beats 93% of human money managers, outperforming the market by 600%” is cited without a study name.
The Free Ticker
The same generous pair as the sibling campaign, both named with tickers, both real, both verifiable:
- Rivian (RIVN), the sell. “My number one stock to avoid right now is Rivian, ticker R-I-V-N… Rivian is burning through $2 billion in cash every single year. It’s already carrying $5 billion in debt. And to keep the lights on, it keeps issuing new shares… On top of that, the shift toward EVs has slowed sharply, just as Rivian needs it most.” The financial pattern matches Rivian’s reported numbers.
- Garmin (GRMN), the buy. “Most people see Garmin as a watch company. They think of fitness trackers, GPS devices, and running watches, but there’s a lot more underneath the surface… Garmin has spent years building one of the largest collections of health, fitness, location, and performance databases in the world. And now it has started capitalizing on this data through an AI powered subscription platform… the future of AI isn’t just about computing power. It’s about real world data. And Garmin collects it, analyzes it, and is increasingly monetizing it.” Garmin Connect+ with AI “Active Intelligence” insights is a real product at $6.99 a month.
The hidden names sit in the Ripping Point Riches report with three drawn fingerprints: a street-corner company “hiding one of the largest real estate empires in America in plain sight” that “has paid its shareholders through every recession”; a chip company where “nearly every NVIDIA chip and every Apple iPhone chip is built by this company. Yet I doubt one in 10 Americans would recognize the ticker”; and a financial-infrastructure name “earning fees from virtually every major financial decision made anywhere on earth.” Those are the Revealer’s assignments; we identify nothing here.
What You Get
The product is the N.E.W. System (New Engine of Wealth System): “30 days of risk-free access to everything my team and I have built to face the ripping point at a steep discount off our normal price with our full money-back guarantee.”
Included:
- Ripping Point Riches: “the seven top scoring stocks set to thrive in the AI disruption.”
- The Ripping Point Casualties: “The 7 Low Scoring Stocks You May Already Own.”
- The quarterly portfolio with monthly updates and the position-sizing calculator: “you simply enter that amount into our calculator, and it will spit out exactly how much cash to put into each stock we’re recommending.”
- Full Stansberry Score access: “type in any of 5,300 plus tickers and instantly see whether our algorithms pinpoint it as a winner or a loser. The next time your brother-in-law hypes a stock at Thanksgiving you can check it in 10 seconds.”
- Stansberry GPT: “your personal investment chat bot powered by hundreds of thousands of dollars worth of real-time financial data.”
- The Quick Start Guide, plus a withheld third bonus “I believe it’s the single most valuable piece of research my firm publishes.”
Price: withheld behind the order button, anchored against the 2-and-20 hedge-fund fee structure (“you’d end up paying a total of $20,000 to me just in fees”). Guarantee: “If you’re not completely thrilled with your decision in the next 30 days, simply contact our U.S.-based concierge team and we’ll refund every penny. And you keep everything.” Real cost: recurring subscription with renewal at the standard price after the discounted term; order-form cross-sells apply.
Our Take
Of the two Tilson campaigns running this week, this one is the memoir cut, and we marginally prefer it: the personal-witness opening is authentic, the inequality montage is drawn from real data, and dropping the manufactured midnight deadline in favor of the “next six months” framing makes the urgency more honest even if it is vaguer. The free picks are the strongest part of the package. The Garmin thesis, a large cap monetizing one of the world’s largest health-and-location data troves through an AI subscription, is a real, checkable idea a reader can act on without spending a dollar. The Rivian warning is directionally sound on the financials, though “get out immediately” is a decision that belongs to the holder, not the presenter, and tax circumstances differ.
The counterweights: the backtest claims are unaudited and presented at their shiniest, the “less risk” claim is undefined, and the opening act’s politics, described here only as the presentation’s framing, are atmosphere rather than analysis; the investing case neither requires nor benefits from them. If the K-shaped thesis is right, a systematic screen with sell discipline is a reasonable way to express it; if it is wrong, the quarterly rebalancing will at least force the portfolio to update with the evidence.
Who is this for? Readers who want a rules-based, tool-driven portfolio for the AI bifurcation rather than a list of story stocks, and who will use the 30-day window to stress-test the score against their own holdings. Watch it for the Garmin and Rivian reasoning even if you never subscribe; that half hour is worth more than most full presentations in this genre.
Where to Learn More
- For the sibling campaign with the same system and a November 4 election clock, see our America’s AI Civil War review.
- For our earlier Tilson coverage, see the Rushmore Gold review.
- For the same market-bifurcation thesis from a ratings-system angle, see our 401(ai) review.
- Have a promo you want us to vet? Submit it here.
- Ready to try the N.E.W. System? Click here to learn more.
NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.